527 related articles for article (PubMed ID: 20685286)
1. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
Aylward LL; Kirman CR; Blount BC; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria.
Kirman CR; Aylward LL; Blount BC; Pyatt DW; Hays SM
J Expo Sci Environ Epidemiol; 2012; 22(1):24-34. PubMed ID: 21989501
[TBL] [Abstract][Full Text] [Related]
3. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
Liao KH; Tan YM; Clewell HJ
Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
[TBL] [Abstract][Full Text] [Related]
4. Biomonitoring Equivalents for bisphenol A (BPA).
Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):18-24. PubMed ID: 20541576
[TBL] [Abstract][Full Text] [Related]
5. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
[TBL] [Abstract][Full Text] [Related]
6. Biomonitoring Equivalents for benzene.
Hays SM; Pyatt DW; Kirman CR; Aylward LL
Regul Toxicol Pharmacol; 2012 Feb; 62(1):62-73. PubMed ID: 22178585
[TBL] [Abstract][Full Text] [Related]
7. Biomonitoring equivalents for hexachlorobenzene.
Aylward LL; Hays SM; Gagné M; Nong A; Krishnan K
Regul Toxicol Pharmacol; 2010 Oct; 58(1):25-32. PubMed ID: 20547196
[TBL] [Abstract][Full Text] [Related]
8. QSARs for PBPK modelling of environmental contaminants.
Peyret T; Krishnan K
SAR QSAR Environ Res; 2011 Mar; 22(1-2):129-69. PubMed ID: 21391145
[TBL] [Abstract][Full Text] [Related]
9. Biomonitoring Equivalents for triclosan.
Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):10-7. PubMed ID: 20541577
[TBL] [Abstract][Full Text] [Related]
10. Biomonitoring equivalents for inorganic arsenic.
Hays SM; Aylward LL; Gagné M; Nong A; Krishnan K
Regul Toxicol Pharmacol; 2010 Oct; 58(1):1-9. PubMed ID: 20547195
[TBL] [Abstract][Full Text] [Related]
11. Biomonitoring equivalents for DDT/DDE.
Kirman CR; Aylward LL; Hays SM; Krishnan K; Nong A
Regul Toxicol Pharmacol; 2011 Jul; 60(2):172-80. PubMed ID: 21466830
[TBL] [Abstract][Full Text] [Related]
12. Blood/air distribution of volatile organic compounds (VOCs) in a nationally representative sample.
Jia C; Yu X; Masiak W
Sci Total Environ; 2012 Mar; 419():225-32. PubMed ID: 22285084
[TBL] [Abstract][Full Text] [Related]
13. Health risk assessment of personal inhalation exposure to volatile organic compounds in Tianjin, China.
Zhou J; You Y; Bai Z; Hu Y; Zhang J; Zhang N
Sci Total Environ; 2011 Jan; 409(3):452-9. PubMed ID: 21078521
[TBL] [Abstract][Full Text] [Related]
14. Human biomonitoring: state of the art.
Angerer J; Ewers U; Wilhelm M
Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
[TBL] [Abstract][Full Text] [Related]
15. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
Boogaard PJ; Hays SM; Aylward LL
Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
[TBL] [Abstract][Full Text] [Related]
16. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
Pelekis M; Gephart LA; Lerman SE
Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
[TBL] [Abstract][Full Text] [Related]
17. Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.
Chiu WA; White P
Risk Anal; 2006 Jun; 26(3):769-80. PubMed ID: 16834633
[TBL] [Abstract][Full Text] [Related]
18. Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.
Nong A; Krishnan K
Regul Toxicol Pharmacol; 2007 Jun; 48(1):93-101. PubMed ID: 17367907
[TBL] [Abstract][Full Text] [Related]
19. Biomonitoring equivalents for di-isononyl phthalate (DINP).
Hays SM; Aylward LL; Kirman CR; Krishnan K; Nong A
Regul Toxicol Pharmacol; 2011 Jul; 60(2):181-8. PubMed ID: 21466828
[TBL] [Abstract][Full Text] [Related]
20. Biomonitoring Equivalents (BE) dossier for trihalomethanes.
Aylward LL; LaKind JS; Hays SM
Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S68-77. PubMed ID: 18579267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
